Wall Street
Price Targets

NK8 Price Targets Summary
NuVasive Inc

There are no price targets for NK8.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
NuVasive Inc Competitors:
Price Targets
FDMT
4D Molecular Therapeutics Inc
256% Upside

Revenue
Forecast

6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 8 years the compound annual growth rate for NuVasive Inc's revenue is 6%.

Operating Income
Forecast

4% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
4% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
NuVasive Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NK8's stock price target?
Not Available

NK8 doesn't have any price targets made by Wall Street professionals.

Back to Top